7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 
      
    		                                                                       
      cash flows from operating activities:
    		                                                                       
      net income
    		274,610,000 293,989,000 242,677,000 216,149,000 232,841,000 203,298,000 235,579,000 194,521,000 212,231,000 224,236,000 214,054,000 172,207,000 180,938,000 131,979,000 193,965,000 162,771,000 175,178,000 202,606,000 204,289,000 174,958,000 146,321,000 148,996,000 111,856,000 90,544,000 108,838,000 125,701,000 102,709,000 85,677,000 93,214,000 108,680,000 89,476,000 38,290,000 70,514,000 85,407,000 69,058,000  56,452,000 67,206,000 46,025,000  44,229,000 56,938,000 46,578,000  52,163,000 57,244,000 46,593,000  45,692,000 53,998,000 44,867,000  38,496,000 48,654,000 36,606,000  34,715,000 37,197,000 33,028,000 30,961,000 31,536,000 33,667,000 26,071,000 23,555,000 25,699,000 39,364,000 27,551,000 25,528,000 25,795,000 21,664,000 21,027,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                       
      depreciation and amortization
    		36,627,000 35,772,000 34,063,000 33,706,000 34,133,000 32,193,000 29,904,000 29,737,000 28,985,000 27,855,000 28,331,000 28,720,000 28,547,000 28,122,000 26,511,000 27,695,000 26,467,000 25,377,000 25,057,000 24,561,000 24,651,000 23,582,000 23,204,000 22,589,000 22,446,000 21,621,000 21,355,000 20,604,000 20,878,000 20,892,000 20,804,000 21,520,000 20,727,000 20,586,000 20,307,000  19,767,000 19,664,000 18,546,000  18,283,000 16,790,000 16,154,000  15,521,000 14,695,000 13,394,000  13,773,000 13,844,000 13,513,000  12,045,000 11,879,000 11,464,000  11,485,000 11,386,000 11,246,000 12,555,000 12,506,000 11,665,000 13,047,000 12,649,000 12,190,000 12,585,000 11,395,000 11,562,000 10,267,000 10,224,000 9,047,000 
      impairment charge
    		    0 0 250,000         0 1,353,000   508,000        0         0 1,118,000 1,110,000                                 
      benefit from credit losses
    		1,619,000 1,470,000 2,890,000  1,337,000 2,213,000 1,530,000  1,607,000 1,532,000 2,325,000  1,754,000 1,266,000 2,092,000  951,000 582,000 186,000  -117,000 1,123,000 4,229,000                                                 
      deferred income taxes
    		93,248,000 2,479,000 3,948,000 4,676,000 -6,849,000 -19,450,000 -2,571,000 -33,557,000 -1,817,000 -9,175,000 -3,757,000 1,825,000 -13,373,000 -18,489,000 -5,028,000 -7,426,000 -144,000 -1,051,000 5,244,000                                                     
      share-based compensation expense
    		14,433,000 14,854,000 14,615,000 14,258,000 15,918,000 15,719,000 14,400,000 15,223,000 15,224,000 15,362,000 13,930,000 13,279,000 12,948,000 12,370,000 11,173,000 9,713,000 9,530,000 9,637,000 8,875,000 7,943,000 7,927,000 7,797,000 7,284,000 16,655,000 9,391,000 6,898,000 6,334,000 6,209,000 6,596,000 6,392,000 5,960,000 5,755,000 6,020,000 6,087,000 5,655,000  5,094,000 5,005,000 4,922,000  5,118,000 4,990,000 4,652,000  4,643,000 4,712,000 4,108,000  4,157,000 4,159,000 3,949,000  3,996,000 3,536,000 3,965,000  3,185,000 3,258,000 3,344,000 2,774,000 2,908,000 3,011,000 2,930,000 2,418,000 2,485,000 2,720,000 2,878,000 2,202,000 2,461,000 1,697,000 2,416,000 
      other
    		1,753,000 1,035,000 456,000 184,000 67,000 58,000 909,000 532,000 145,000 205,000 -362,000 613,000 832,000 965,000 235,000 217,000 1,102,000 967,000 333,000 891,000 -211,000 712,000 -13,000 -243,000 750,000 119,000 628,000 -1,485,000 772,000 522,000 1,091,000 453,000 310,000 -654,000 860,000  -380,000 954,000 586,000  -722,000                               
      changes in assets and liabilities:
    		                                                                       
      accounts receivable
    		-7,697,000 -29,649,000 -45,240,000 27,807,000 26,894,000 -29,140,000 -53,841,000 686,000 6,601,000 -17,025,000 -44,133,000 -6,337,000 18,733,000 -16,263,000 -37,531,000 15,909,000 1,671,000 4,014,000 -54,735,000 11,687,000 -15,132,000 -19,215,000 -38,062,000 1,979,000 13,248,000 -4,278,000 -33,421,000 14,640,000 -169,000 -11,072,000 -21,800,000 -6,194,000 13,676,000 -12,971,000 -19,429,000  7,000,000 -2,143,000 -21,504,000  6,102,000 -5,688,000 -51,438,000  1,322,000 11,921,000 -21,707,000  11,366,000 -439,000 -23,722,000  8,032,000       -23,000 5,969,000 -1,029,000 -6,072,000 -5,266,000 4,495,000 4,048,000 -13,543,000 -11,257,000 3,792,000 -1,642,000 -16,428,000 
      inventories
    		1,879,000 -6,244,000 2,163,000 -3,245,000 -18,543,000 -3,801,000 -2,412,000 2,996,000 7,259,000 -15,019,000 -23,887,000 -22,110,000 -50,272,000 -30,495,000 -18,854,000 -6,028,000 -26,479,000 -12,493,000 -7,919,000 6,206,000 4,163,000 -14,820,000 -14,434,000 -724,000 -13,671,000 -8,390,000 -14,521,000 1,792,000 -10,590,000 -8,755,000 -8,070,000 3,904,000 -4,116,000 -13,481,000 -5,369,000  -2,717,000 -1,550,000 1,764,000  -11,215,000 -5,881,000 -10,142,000  -7,063,000 -7,775,000 2,200,000  -4,706,000 6,818,000 -8,472,000  -4,040,000 -6,589,000 897,000     14,368,000 -1,269,000 1,191,000 -8,067,000 -4,331,000 -7,177,000 -6,483,000 -477,000 -2,508,000 -4,524,000 4,885,000 -3,083,000 
      other assets and liabilities
    		-21,038,000 -129,581,000 -10,325,000 -35,393,000 -64,055,000 40,199,000 -21,416,000 31,584,000 6,334,000 -18,929,000 -5,307,000 -15,283,000 7,163,000 -41,825,000 -52,904,000 -3,184,000 3,201,000 1,919,000 -57,081,000 29,659,000 26,039,000 69,421,000 -64,881,000 19,982,000 -8,948,000 3,779,000 -49,601,000 18,483,000 -2,433,000 -3,479,000 -52,302,000 58,152,000 10,692,000 17,105,000 -38,531,000  16,374,000 19,790,000 -27,516,000                                 
      accounts payable
    		7,136,000 -3,990,000 -8,123,000 5,739,000 -1,455,000 8,252,000 -4,450,000 6,242,000 -2,644,000 -7,482,000 3,327,000 7,397,000 2,805,000 -2,719,000 -4,016,000 10,596,000 -3,175,000 1,352,000 2,460,000 469,000 7,241,000 -4,974,000 -1,755,000 776,000 5,211,000 -4,729,000 699,000 1,170,000 -1,339,000 1,942,000 -1,939,000 4,931,000 -4,962,000 5,109,000 -3,687,000  -2,595,000 1,900,000 -1,801,000  151,000 1,340,000 -4,332,000  6,539,000 -1,520,000 1,857,000  -365,000 -1,105,000 3,654,000  1,303,000 6,454,000 548,000  1,799,000 -773,000 5,081,000 -2,288,000 -5,184,000 2,631,000 -4,315,000 -695,000 3,815,000 92,000 -7,539,000 10,599,000 -6,717,000 1,034,000 935,000 
      deferred revenue
    		-230,000 5,608,000 838,000 -3,643,000 -209,000 -1,229,000 703,000 315,000 -1,492,000 -1,246,000 -609,000 -7,600,000 -1,075,000 -1,407,000 -937,000 -64,000 -2,450,000 -2,750,000 -2,287,000 -2,940,000 -3,738,000 -4,285,000 -2,410,000 -1,534,000 -3,977,000 -3,751,000 -3,098,000 -1,405,000 -3,062,000 -1,925,000 -1,327,000 1,272,000 381,000 1,429,000 469,000  710,000 2,451,000 637,000  -1,982,000 -1,859,000 1,153,000  3,427,000 4,912,000 3,227,000  1,686,000 1,495,000 869,000  2,649,000    12,000 2,034,000 524,000 1,623,000 -16,000 -477,000 -205,000 -278,000 -276,000 82,000 -333,000 -236,000 -110,000 716,000 167,000 
      net cash from operating activities
    		402,340,000 185,743,000 237,962,000 262,025,000 220,079,000 248,312,000 198,585,000 249,851,000 272,433,000 200,314,000 183,912,000 173,428,000 189,000,000 65,850,000 114,706,000 209,964,000 187,205,000 233,955,000 124,422,000 218,934,000 193,116,000 208,142,000 27,871,000 155,413,000 132,265,000 137,102,000 34,378,000 135,648,000 110,708,000 118,830,000 34,898,000 121,126,000 110,684,000 110,192,000 31,274,000 100,115,000 100,315,000   73,896,000 76,946,000   27,303,000 93,263,000 81,762,000 33,518,000 66,267,000 79,727,000 79,318,000 20,684,000 76,794,000 75,208,000 63,092,000 25,218,000 48,850,000 54,898,000 55,880,000 19,205,000 59,449,000 44,622,000   33,494,000 41,674,000   39,931,000 32,057,000   
      capex
    		-31,114,000 -34,102,000 -30,026,000 -29,255,000 -28,089,000 -33,305,000 -30,273,000 -32,556,000 -34,094,000 -27,470,000 -39,511,000 -49,229,000 -37,685,000 -30,086,000 -31,838,000 -31,788,000 -45,017,000 -22,581,000 -20,163,000 -14,190,000 -19,210,000 -24,556,000 -49,002,000 -45,911,000 -37,071,000 -33,781,000 -38,206,000 -33,109,000 -31,265,000 -27,651,000 -23,726,000 -20,014,000 -15,804,000 -14,919,000 -23,647,000 0 -12,088,000   0 -20,644,000   0 -17,094,000 -14,112,000 -11,298,000 0 -16,908,000 -23,938,000 -19,761,000 0 -13,754,000 0 0 0 0 0 0 -13,803,000 -14,528,000   -24,255,000 -22,418,000   0 -15,488,000   
      free cash flows
    		371,226,000 151,641,000 207,936,000 232,770,000 191,990,000 215,007,000 168,312,000 217,295,000 238,339,000 172,844,000 144,401,000 124,199,000 151,315,000 35,764,000 82,868,000 178,176,000 142,188,000 211,374,000 104,259,000 204,744,000 173,906,000 183,586,000 -21,131,000 109,502,000 95,194,000 103,321,000 -3,828,000 102,539,000 79,443,000 91,179,000 11,172,000 101,112,000 94,880,000 95,273,000 7,627,000 100,115,000 88,227,000   73,896,000 56,302,000   27,303,000 76,169,000 67,650,000 22,220,000 66,267,000 62,819,000 55,380,000 923,000 76,794,000 61,454,000 63,092,000 25,218,000 48,850,000 54,898,000 55,880,000 19,205,000 45,646,000 30,094,000   9,239,000 19,256,000   39,931,000 16,569,000   
      cash flows from investing activities:
    		                                                                       
      purchases of property and equipment
    		-31,114,000 -34,102,000 -30,026,000 -29,255,000 -28,089,000 -33,305,000 -30,273,000 -32,556,000 -34,094,000 -27,470,000 -39,511,000 -49,229,000 -37,685,000 -30,086,000 -31,838,000 -31,788,000 -45,017,000 -22,581,000 -20,163,000 -14,190,000 -19,210,000 -24,556,000 -49,002,000 -45,911,000 -37,071,000 -33,781,000 -38,206,000 -33,109,000 -31,265,000 -27,651,000 -23,726,000 -20,014,000 -15,804,000 -14,919,000 -23,647,000  -12,088,000 -15,962,000 -21,906,000  -20,644,000 -23,856,000 -23,017,000  -17,094,000 -14,112,000 -11,298,000  -16,908,000 -23,938,000 -19,761,000  -13,754,000       -13,803,000 -14,528,000 -11,973,000 -9,114,000 -24,255,000 -22,418,000 -25,515,000 -17,049,000     
      acquisition of intangible assets
    		            0 0 -10,000,000      0                                                   
      equity investments
    		                                                                       
      acquisition of a business
    		                        0                                               
      proceeds from net investment hedges
    		349,000 474,000 416,000 416,000 415,000 398,000 329,000 2,121,000                                                                
      net cash used by investing activities
    		-44,871,000 -33,628,000 -29,610,000 -39,843,000 -27,368,000 -32,907,000 -106,944,000 -30,435,000 -27,838,000 -27,470,000 -39,511,000 -49,229,000 -49,197,000 -55,086,000 -41,838,000 -44,040,000 -49,677,000 -174,663,000 -24,587,000  -19,460,000 -24,556,000 -49,670,000         -24,487,000 -41,487,000 -43,702,000 -29,012,000 -14,278,000 -22,946,000 -29,763,000 -23,799,000 -26,013,000 -54,806,000 -66,967,000 -160,620,000 -35,618,000 -23,449,000 -8,712,000 -12,634,000 -17,827,000 -27,374,000 -23,938,000 -16,920,000 -24,920,000 -16,349,000       -14,012,000 -20,702,000 -12,028,000 -6,879,000 -17,404,000 -22,684,000 -26,699,000 -24,808,000 -25,927,000   -56,041,000 
      cash flows from financing activities:
    		                                                                       
      borrowings under credit facility
    		-124,000,000 259,500,000 69,500,000                                                                     
      payments of senior notes
    		0   0                                                                    
      repurchases of common stock
    		-240,195,000 -338,105,000 -400,890,000 -245,992,000 -220,757,000 -215,521,000 -154,764,000 -36,850,000    -74,020,000 -172,631,000 -306,765,000 -266,295,000 -244,756,000 -181,234,000 -188,525,000 -132,262,000 0 0 0 -182,815,000 -140,689,000 -85,975,000 -20,692,000 -54,302,000 -105,607,000 -73,828,000 -106,397,000 -83,487,000 -53,872,000 -57,895,000 -106,888,000 -63,910,000  -15,026,000 -23,056,000 -53,480,000  -88,960,000 -86,450,000 -133,647,000  -272,342,000 -126,347,000 -70,279,000  -76,575,000 -142,557,000 -63,778,000  -67,597,000                   
      proceeds from exercises of stock options and employee stock purchase plans
    		50,970,000 17,330,000 7,193,000 13,255,000 4,996,000 5,362,000 20,879,000 11,330,000 12,618,000 10,290,000 12,796,000 12,490,000 4,878,000 6,726,000 11,653,000 9,137,000 10,057,000 9,777,000 17,594,000 12,098,000 18,617,000 10,403,000 10,210,000 7,367,000 9,086,000 8,102,000 11,551,000 3,606,000 12,690,000 7,354,000 14,551,000 7,308,000 8,144,000 10,644,000 12,526,000  11,261,000 11,794,000 5,760,000  3,571,000 3,325,000 12,325,000  3,654,000 3,743,000 10,964,000  5,314,000 3,462,000 12,958,000  6,713,000 7,198,000 12,169,000  5,609,000 9,963,000 6,483,000 3,262,000 6,216,000 3,607,000 3,281,000         
      shares withheld for statutory tax withholding payments on restricted stock
    		-85,000 -970,000 -6,124,000 -45,000 -218,000 -79,000 -10,189,000 -68,000 -231,000 -79,000 -9,597,000 -54,000 -162,000 -52,000 -10,338,000 -61,000                                                        
      net cash used by financing activities
    		-313,310,000 -165,631,000 -330,321,000 -232,782,000 -290,979,000 -210,238,000 -144,074,000 -101,844,000 -43,038,000 -151,033,000 -146,081,000 -116,720,000 -148,829,000 -91,907,000 -13,480,000 -165,820,000 -221,726,000   398,000 -104,184,000   -74,389,000 -99,751,000 -109,488,000 -2,781,000 -117,806,000 -84,294,000   -78,058,000 -67,871,000   -76,612,000    -59,158,000    42,339,000 -76,268,000   -33,055,000 -40,331,000   -49,847,000 -36,530,000       -44,755,000 -22,404,000   -20,680,000    -12,521,000    
      net effect of changes in exchange rates on cash
    		-587,000 14,140,000 -2,327,000 -9,770,000 5,314,000 -1,010,000 -4,066,000 4,664,000 -2,699,000 -340,000 501,000 5,891,000 -6,160,000 -9,113,000 776,000 -853,000 -2,733,000 1,896,000 -2,949,000 4,699,000 822,000 1,843,000 -4,033,000 1,217,000 -2,037,000 700,000 -569,000 -1,081,000 119,000 -5,141,000 1,335,000 75,000 1,718,000 2,477,000 1,932,000 -4,396,000 811,000 201,000 3,330,000 -881,000 -4,479,000 1,325,000 -1,913,000 -4,223,000 -5,859,000 344,000 1,221,000 -1,138,000 1,776,000 -1,414,000 -1,638,000 518,000 -228,000 996,000 1,269,000 429,000    -682,000 1,468,000           
      net decrease in cash and cash equivalents
    		43,572,000      -56,499,000    -1,179,000  -15,186,000      -32,765,000    -8,931,000  -6,849,000 -5,771,000 -7,178,000                                        -140,000  8,919,000 -4,349,000 -7,729,000 
      cash and cash equivalents at beginning of period
    		0 0 288,266,000 0 0 0 453,932,000 0 0 0 112,546,000 0 0 0 144,454,000 0 0 0 383,928,000 0 0 0 90,326,000 0 0 0 123,794,000 0 0 0 187,675,000 0 0 0 154,901,000  0 0 128,994,000  0 0 322,536,000  0 0 279,058,000  0 0 223,986,000  0 0 156,915,000  0 0 106,728,000 0 0 0 78,868,000 0 0 0 60,360,000 0 0 0 61,666,000 
      cash and cash equivalents at end of period
    		43,572,000 624,000 163,970,000 -20,370,000 -92,954,000 4,157,000 397,433,000 122,236,000 198,858,000 21,471,000 111,367,000 13,370,000 -15,186,000 -90,256,000 204,618,000 -749,000 -86,931,000 -119,029,000 351,163,000 208,341,000 70,294,000 23,898,000 81,395,000 -13,670,000 -6,849,000 -5,771,000 116,616,000 -23,083,000 -27,682,000 15,330,000 159,229,000 18,656,000 3,044,000 5,567,000 160,408,000  8,933,000 8,186,000 132,953,000  -22,002,000 -19,008,000 182,160,000  -12,313,000 18,845,000 286,203,000  13,798,000 22,649,000 228,364,000  22,101,000 5,939,000 153,459,000  15,537,000 11,621,000 106,354,000 0 2,984,000 17,449,000 86,295,000 -5,718,000 9,321,000 15,045,000 60,220,000 1,853,000 8,919,000 -4,349,000 53,937,000 
      supplemental cash flow information:
    		                                                                       
      unpaid property and equipment, reflected in accounts payable and accrued liabilities
    		-1,682,000 -2,242,000 10,702,000  2,083,000 -6,860,000 15,182,000  -4,120,000 2,995,000 12,453,000  9,321,000 -676,000 11,016,000  5,058,000 3,084,000 6,592,000  -4,962,000 -1,453,000 14,123,000  7,563,000                                               
      the accompanying notes are an integral part of these condensed consolidated financial statements.
    		                                                                       
      net increase in cash and cash equivalents
    		  -124,296,000 -20,370,000 -92,954,000   122,236,000 198,858,000      60,164,000 -749,000 -86,931,000   208,341,000 70,294,000       -23,083,000 -27,682,000 15,330,000 -28,446,000 18,656,000 3,044,000 5,567,000 5,507,000 4,829,000 8,933,000 8,186,000 3,959,000 -12,156,000 -22,002,000 -19,008,000 -140,376,000 29,801,000 -12,313,000 18,845,000 7,145,000 14,247,000 13,798,000 22,649,000 4,378,000 2,545,000 22,101,000   23,403,000 15,537,000   0 2,984,000 17,449,000 7,427,000 -5,718,000 9,321,000       
      impairment charges
    		            0                                                           
      benefit from uncollectible accounts
    		                               485,000 571,000    590,000    360,000 939,000 509,000  890,000 337,000 451,000  446,000 136,000 644,000  314,000 82,000 601,000  910,000 211,000 385,000 252,000 20,000 408,000 246,000 -529,000 885,000 301,000 523,000 238,000 81,000 179,000 116,000 
      acquisitions of intangible assets
    		                      -668,000         -2,000,000             0 0 -175,000   0 -659,000                     
      acquisitions of businesses, net of cash acquired
    		                                          -383,000                             
      (payments) borrowings on credit facility
    		                                                                       
      debt issuance costs
    		                   -30,000 -7,000   0 -12,000 -112,000 -30,000                                             
      payments of acquisition-related contingent consideration and holdbacks
    		        -99,000    -2,914,000                                                           
      the accompanying notes are an integral part of these consolidated financial statements.
    		                                                                       
      repayments under credit facility
    		                                                                       
      acquisitions of a business
    		     0 -77,000,000                                                                 
      payments of acquisition-related holdbacks
    		          -1,780,000                                                             
      cash paid for income taxes
    		     77,685,000 13,233,000  63,733,000 89,927,000 7,200,000  51,395,000 116,925,000 11,400,000  14,180,000 69,752,000 12,171,000  49,926,000 17,963,000 12,020,000                                                 
      (repayments) borrowings on credit facility
    		                                                                       
      purchase of minority interest
    		                                                                       
      payment of acquisition-related contingent consideration and holdbacks
    		                                                                       
      equity investment
    		            0                                                           
      acquisitions of a business, net of cash acquired
    		                -4,660,000 -152,082,000 -4,424,000              0 -12,180,000 -2,349,000      -7,817,000    -6,355,000 0 -1,161,000                         
      (repayments) borrowings under credit facility
    		        -14,000,000 -167,500,000 -147,500,000                                                             
      payment of senior debt
    		            0 0 -75,000,000                                                         
      proceeds from maturity of net investment hedges
    		                                                                       
      borrowings (repayments) on credit facility
    		                                                                       
      issuance of senior notes
    		                   0 0   0 0 0 100,000,000                                             
      borrowings under revolving credit facility
    		            22,000,000 211,000,000 326,500,000                                                         
      acquisitions of intangible assets and equity investments
    		                                                                       
      borrowings (repayments) on revolving credit facilities
    		                                -17,750,000                                       
      acquisition of intangible assets and equity investments
    		                                                                       
      repayments on revolving credit facilities
    		                    -121,933,000    -22,013,000 -95,495,000 -52,024,000          -70,000,000                                   
      issuance of senior debt
    		                                                                       
      payments of acquisition-related contingent considerations and holdbacks
    		                0                                                       
      acquisition of intangible assets and equity investment
    		                                                                       
      shares withheld for statutory tax withholding on restricted stock
    		                 31,000 -14,983,000 -11,574,000 -361,000 -64,000 -8,604,000 -204,000 -277,000 -169,000 -7,403,000 -265,000 -390,000 -165,000 -8,555,000 -244,000 -370,000 -156,000 -7,303,000                                     
      borrowings on revolving credit facilities
    		                                  60,000,000    49,000,000    500,000  -9,000,000 69,000,000 38,000,000   107,500,000 48,000,000  21,417,000     -23,424,000 38,523,000   -11,237,000 15,019,000 -12,549,000 6,151,000 18,006,000 67,942,000     
      net cash (used) provided by financing activities
    		                  -129,651,000            -324,991,000                -14,960,000                         
      (benefit of) benefit from deferred income taxes
    		                                              -835,000                         
      purchases of marketable securities
    		                                                                       
      proceeds from the sale and maturities of marketable securities
    		                           0 0 0 284,125,000 61,943,000 68,913,000 68,427,000 87,476,000  44,162,000 37,929,000 70,186,000  14,672,000 6,811,000 3,228,000                             
      net cash (used) provided by investing activities
    		                       -95,911,000 -37,326,000 -34,085,000 -38,206,000                                             
      repayment on revolving credit facilities
    		                                                                       
      payment of acquisition-related contingent consideration
    		                   -96,000 -500,000   -120,000 -560,000 -1,122,000 -573,000 0 -266,000        -916,000 -633,000 -2,084,000                                 
      acquisitions of a business and equity investment, net of cash acquired
    		                                                                       
      benefit of deferred income taxes
    		                     -195,000 2,853,000  -1,023,000 132,000 3,294,000   5,633,000 3,005,000   750,000 1,941,000    2,520,000  -2,594,000    -1,504,000                      -999,000 -864,000 -3,864,000 -2,507,000 -1,839,000 
      borrowing (repayments) on revolving credit facilities
    		                      198,110,000                                                 
      net cash provided (used) by financing activities
    		                      16,901,000            1,313,000       -33,532,000 36,801,000        2,252,000                   -47,981,000 49,289,000 
      benefit of (benefit from) deferred income taxes
    		                           -11,641,000                                            
      acquisitions of intangible assets and equity investment
    		                                                                       
      acquisitions of businesses
    		                                                                       
      (repayment) borrowings on revolving credit facilities
    		                                                                       
      purchase of marketable securities
    		                            0 0 -87,000  -94,276,000 -85,030,000 -90,492,000  -55,020,000 -51,730,000 -72,079,000  -41,017,000 -49,922,000 -140,448,000                             
      amortization on marketable securities
    		                                          91,000                             
      tax benefit from share-based compensation arrangements
    		                                    -5,434,000 -2,728,000 -2,063,000  -1,298,000 -1,033,000 -7,713,000  -1,621,000 -1,213,000 -6,747,000  -1,608,000 -520,000 -5,310,000                     
      net cash provided (used) by investing activities
    		                           -39,844,000 -54,215,000 -27,651,000 260,312,000                                         
      debt issue costs
    		                                    0 0 -57,000  -72,000 -37,000 -90,000  -201,000 -1,017,000 -139,000                         
      (repayments) borrowings on revolving credit facilities
    		                            -22,500,000 29,500,000 -247,500,000          44,500,000                               
      benefit from deferred income taxes
    		                                                  1,169,000    2,501,000    769,000             
      (benefit from) benefit of deferred income taxes
    		                                                                       
      adjustments to reconcile net income to net cash provided (used) by operating activities:
    		                                                                       
      benefit from (benefit of) deferred income taxes
    		                                    4,727,000      565,000                 -435,000   1,465,000         
      issuance of long-term debt
    		                                                                       
      net cash provided (used) by operating activities
    		                                      23,226,000                        12,624,000         
      net cash from financing activities
    		                                      1,202,000                        3,285,000    24,768,000     
      other assets
    		                                        8,249,000 17,313,000 15,479,000  -425,000 -4,262,000 1,312,000  310,000 -1,894,000 6,301,000  -4,237,000 4,631,000 2,662,000    1,441,000 -4,716,000 -358,000 -2,947,000 179,000 -3,365,000 -295,000 84,000 -1,540,000 -7,181,000 103,000 -2,192,000 712,000 
      accrued liabilities
    		                                        3,086,000 -1,364,000 -26,225,000  19,560,000 6,887,000 -10,231,000  8,418,000 5,232,000 -16,919,000  21,835,000    9,015,000   5,946,000 -1,818,000 8,971,000 -12,394,000 2,067,000 3,924,000 17,670,000 -18,190,000 13,772,000 8,212,000 21,393,000 -11,453,000 
      proceeds from sale of equity investment
    		                                            0                           
      issuance of long term debt
    		                                          150,000,000                             
      payment of notes payable
    		                                            0 -1,141,000 -253,000  -378,000 -242,000 -238,000  -218,000                   
      adjustments to reconcile net income to net cash (used) provided by operating activities:
    		                                                                       
      gain on disposal of property and equipment
    		                                          -33,000                             
      increase in deferred compensation liability
    		                                          58,000   93,000 -86,000  137,000 -25,000 114,000  -391,000 -17,000 88,000    101,000 114,000            
      net cash (used) provided by operating activities
    		                                          -14,644,000                             
      acquisition of intangible asset
    		                                                                       
      proceeds from disposition of pharmaceutical product lines
    		                                                0 0 3,500,000  0 0 3,000,000     2,000,000 0 0 1,377,000         
      loss on disposal of property and equipment
    		                                                149,000 44,000 27,000  155,000 16,000 310,000  58,000 350,000 1,092,000 150,000 147,000           
      impairment of property and equipment
    		                                                                       
      gain on sale of equity investment
    		                                                                       
      (gain) loss on disposal of property and equipment
    		                                              -18,000                         
      proceeds from sale of property and equipment
    		                                                    5,000 136,000 82,000  22,000 37,000 27,000 23,000 980,000 30,000 1,046,000         
      acquisition of a business, net of cash acquired
    		                                                                       
      borrowings (payments) on revolving credit facilities
    		                                                           -24,032,000         -8,796,000 5,316,000 74,511,000 
      acquisitions of intangible asset
    		                                                                       
      (payments) borrowings on revolving credit facilities
    		                                                                       
      tax benefit from exercises of stock options and vesting of restricted stock units
    		                                                    -3,155,000 -17,872,000 7,018,000  3,921,000 6,054,000 3,318,000 -1,343,000 -2,496,000 -1,194,000 -161,000         
      changes in assets and liabilities, net of acquisitions:
    		                                                                       
      purchase of treasury stock
    		                                                            -18,241,000 -24,739,000 -14,986,000  -20,098,000 -50,976,000 -51,355,000 -18,703,000 -7,151,000 -57,714,000 -34,819,000 
      write-down of marketable securities
    		                                                           0 0           
      payment of other notes payable
    		                                                           -195,000 -295,000 -246,000 -190,000  -185,000 -180,000 -177,000 -185,000 -170,000 -719,000 -1,323,000 
      acquisitions of equipment leased to customers
    		                                                           -498,000 -474,000 -85,000 -188,000 -174,000 -131,000 -203,000 -226,000 -366,000 -215,000 -287,000 -238,000 
      supplemental disclosures of cash flow information:
    		                                                                       
      interest paid
    		                                                          373,000 550,000 489,000 629,000 1,105,000 1,461,000 1,463,000 970,000 1,182,000 1,432,000 1,270,000 901,000 539,000 
      income taxes paid
    		                                                          3,790,000 11,215,000 11,842,000 19,337,000 3,337,000 6,313,000 12,961,000 14,930,000 15,343,000 5,816,000 12,835,000 3,197,000 14,814,000 
      (gain) loss on disposition of pharmaceutical product lines and related restructuring
    		                                                                       
      write-down of equine digital radiography intangible assets
    		                                                                       
      navigator® inventory write-down and royalty license impairment
    		                                                                   0 0   
      sales and maturities of short- and long-term investments
    		                                                                   0 0 0 35,000,000 
      acquisitions of intangible assets and businesses, net of cash acquired
    		                                                           -1,734,000    0 -135,000 -981,000 -7,533,000 -2,146,000 -2,231,000 -5,196,000 -80,311,000 
      purchases of treasury stock
    		                                                                       
      supplemental disclosure of non-cash information:
    		                                                                       
      market value of common shares received from employees in connection with share-based compensation – see note 16
    		                                                                       
      consideration payable for acquisitions
    		                                                                       
      note receivable on disposition of pharmaceutical product lines
    		                                                                       
      increase in deferred compensation expense
    		                                                                       
      decrease in deferred compensation expense
    		                                                              -100,000         
      net effect of exchange rates on cash
    		                                                              -1,603,000 -1,128,000 -3,927,000 -49,000 2,689,000 370,000 1,770,000 335,000 410,000 
      loss on disposition of pharmaceutical product lines and related restructuring
    		                                                                       
      write-down of long-term assets
    		                                                                       
      partner’s interest in loss of subsidiary
    		                                                                       
      purchases of short- and long-term investments
    		                                                                       
      purchase of land and buildings
    		                                                                       
      payments of other notes payable
    		                                                                       
      market value of common shares received from employees in connection with share-based compensation — see note 15
    		                                                                       
      reduction (increase) in deferred compensation expense
    		                                                                       
      tax benefit from exercises of stock options
    		                                                                -2,708,000 -814,000 -2,384,000 -1,723,000 -3,474,000 -1,066,000 -3,004,000 
      sales and maturities of short-term investments
    		                                                                       
      proceeds from exercises of stock options
    		                                                                5,682,000 3,200,000 5,974,000     
      reduction in deferred compensation expense
    		                                                                 100,000 -131,000     
      adjustments to reconcile net income to net cash used by operating activities:
    		                                                                       
      net cash used by operating activities
    		                                                                  -2,789,000    -1,387,000 
      noncash (gain) on investments
    		                                                                       
      net proceeds from sale of land and buildings
    		                                                                       
      market value of common shares received from employees in connection with share-based compensation – see note 15
    		                                                                       
      receivable for purchase price adjustment of business acquisitions
    		                                                                       
      noncash loss on investments
    		                                                                       
      purchases of property, plant and equipment
    		                                                                    -15,488,000 -15,743,000 -10,492,000 
      proceeds from exercises of options
    		                                                                    5,669,000 4,070,000 7,916,000 
      excess tax benefit from exercises of stock options
    		                                                                      3,004,000 
      changes in assets and liabilities, net of acquisitions and disposals
    		                                                                       
      purchase of short- and long-term investments
    		                                                                       
      purchase of property and equipment
    		                                                                       
      acquisition of equipment leased to customers
    		                                                                       
      acquisition(s) of business(es), net of cash acquired
    		                                                                       
      proceeds from the exercise of stock options
    		                                                                       
      cash and cash equivalents at beginning of year
    		                                                                       
      cash and cash equivalents at end of year
    		                                                                       
      supplemental disclosure of cash flow information:
    		                                                                       
      value of mature shares exchanged in stock option exercises
    		                                                                       
      payable for treasury stock
    		                                                                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.